Shivom Successfully Raised $33 Million in the Private and Pre-sale Round and is Now Only $2 Million Away From Reaching Hardcap

Key Takeaways:

• Shivom’s Presale has now closed
• Closed the sale with 33 $ million dollars
• Main crowdsale that begins on May 3rd

Shivom’s Presale has now closed and we cannot thank you enough for making it an overwhelming success! We closed the sale with 33 $ million dollars and are now all geared up for the main crowdsale that begins on May 3rd, 2018 (next week!) We are now one step closer to achieving our targets and we couldn’t have reached this far without your continued support.

The success of our presale is a great encouragement for us to keep striving to reach our goals of building the world’s best platform to improve the global healthcare system. With your continued supportwe are well on our way to begin developing our platform for safe and secure DNA sequencing and data storage and sharing for advancement of precision medicine.

Shivom’s Journey

About Shivom

Shivom combines blockchain, A.I., DNA sequencing & cryptography to enable secure and personalized medicine. The Shivom platform works on collaboration & integrity, allowing people to own, manage and monetize their data. By creating a web-marketplace, a network of genomic counsellors, and a not-for-profit drug research unit, Shivom will build a global healthcare ecosystem, reaching even low-income countries.

Request Offer